Advisor Group’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$1.96M Buy
33,610
+243
+0.7% +$14.5K 0.01% 821
2019
Q3
$2M Buy
33,367
+57
+0.2% +$3.4K 0.01% 758
2019
Q2
$1.86M Buy
33,310
+2,468
+8% +$127K 0.01% 789
2019
Q1
$1.72M Buy
30,842
+282
+0.9% +$14.4K 0.01% 779
2018
Q4
$1.38M Sell
30,560
-3,858
-11% -$212K 0.01% 787
2018
Q3
$2.27M Buy
34,418
+3,738
+12% +$232K 0.02% 598
2018
Q2
$1.98M Buy
30,680
+1,259
+4% +$78K 0.03% 552
2018
Q1
$1.63M Sell
29,421
-474
-2% -$24.8K 0.02% 644
2017
Q4
$1.43M Buy
29,895
+1,018
+4% +$49.8K 0.02% 701
2017
Q3
$1.46M Buy
28,877
+936
+3% +$48.1K 0.02% 634
2017
Q2
$1.52M Buy
27,941
+13
+0% +$621 0.03% 571
2017
Q1
$1.18M Sell
27,928
-82
-0.3% -$3.5K 0.02% 641
2016
Q4
$1.2M Buy
28,010
+380
+1% +$15.4K 0.03% 592
2016
Q3
$1.14M Buy
27,630
+228
+0.8% +$9.55K 0.03% 588
2016
Q2
$1.09M Buy
+27,402
New +$986K 0.03% 582

Other funds holding IART

Advisor Group's IART Position: Q4 2019 in Review

Advisor Group increased its Integra LifeSciences (IART) stake by 0.73% in Q4 2019, buying an estimated $14.5K and bringing the position to 33,610 shares worth $1.96M. The position accounts for 0.01% of the portfolio, ranked #821.

Advisor Group first reported a position in IART in Q2 2016 and has held it in 15 quarters since. The position peaked at $2.27M in Q3 2018. 279 funds tracked by Wall St. Rank hold IART as of Q4 2019.

  • Advisor Group held 33,610 shares of Integra LifeSciences worth $1.96M as of Q4 2019.
  • Advisor Group bought 243 Integra LifeSciences shares in Q4 2019, an estimated $14.5K.
  • Integra LifeSciences made up 0.01% of Advisor Group's portfolio in Q4 2019, its #821 holding.
  • Advisor Group first reported a position in Integra LifeSciences in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Integra LifeSciences position peaked at $2.27M in Q3 2018.
  • 279 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.